A detailed history of Capitolis Liquid Global Markets LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 480,400 shares of LLY stock, worth $358 Million. This represents 4.52% of its overall portfolio holdings.

Number of Shares
480,400
Previous 213,700 124.8%
Holding current value
$358 Million
Previous $193 Billion 119.97%
% of portfolio
4.52%
Previous 2.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $206 Million - $256 Million
266,700 Added 124.8%
480,400 $426 Billion
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $74.2 Million - $93 Million
102,300 Added 91.83%
213,700 $193 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $66 Million - $88.3 Million
111,400 New
111,400 $86.7 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capitolis Liquid Global Markets LLC Portfolio

Follow Capitolis Liquid Global Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Liquid Global Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Liquid Global Markets LLC with notifications on news.